Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047567
Status:
TERMINATED
Last Update Posted:
2015-12-14
First Post:
2002-10-08
Brief Title:
Open-label Adjunctive Zonisamide for Bipolar Disorder
Sponsor:
Elan Pharmaceuticals
Organization:
Elan Pharmaceuticals
Organization Data
Organization:
Elan Pharmaceuticals
Class:
INDUSTRY
Study ID:
ELN-345-509
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Elan Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None